| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 304,766 | 301,059 | 297,631 | 294,646 | | Cost of Revenue | 127,155 | 123,219 | 123,731 |
-
| | | Gross Profit | 177,611 | 177,840 | 173,900 | 294,646 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 74,611 | 75,504 | 75,820 | 196,843 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 74,280 | 74,406 | 73,191 | 73,468 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 28,720 | 27,930 | 24,889 | 24,335 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 116 | 81 | 130 | 566 | | Earnings Before Interest And Taxes | 28,836 | 28,011 | 25,019 | 24,901 | | Interest Expense | 20,732 | 21,027 | 21,458 | 19,235 | | Income Before Tax | 8,104 | 6,984 | 3,561 | 5,666 | | Income Tax Expense | 406 | 1,072 | 681 | 697 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 7,698 | 5,912 | 2,880 | 4,969 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,698 | 5,912 | 2,880 | 4,969 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $7,698 | $5,912 | $2,880 | $4,969 |
|
0.67% Nasdaq 
Income Statement
